Multiple Cancers
Next generation cancer immunovirotherapy: heterologous oncolytic prime-boost enhanced with selected immunomodulators
What if there was a way to destroy cancer cells and stimulate a patient’s own immune system to attack tumours, while leaving healthy tissues unharmed?
The Terry Fox Research Institute (TFRI) has...
Read More